AFM
MBOT icon

Anson Funds Management’s Microbot Medical MBOT Stock Holding History

Anson Funds Management’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-2,023
Closed -$854K – 64
2016
Q1 		$854K Buy
+2,023
New +$1.07M 0.12% 49

Other funds holding MBOT

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bourgeon Capital Management Darien, Connecticut $578M AUM 41.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
KA
Kovack Advisors Ft. Lauderdale, Florida $1.87B AUM 29.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Anson Funds Management's MBOT Position: Q2 2016 in Review

Anson Funds Management sold out of Microbot Medical (MBOT) in Q2 2016, closing a stake of 2,023 shares — an estimated $854K sold.

Anson Funds Management first reported a position in MBOT in Q1 2016 and held it in 1 quarter. The position peaked at $854K in Q1 2016. 22 funds tracked by Wall St. Rank hold MBOT as of Q2 2016.

  • Anson Funds Management reported no remaining Microbot Medical position as of Q2 2016 after selling out during the quarter.
  • Anson Funds Management sold 2,023 Microbot Medical shares in Q2 2016, an estimated $854K.
  • Anson Funds Management first reported a position in Microbot Medical in Q1 2016 and held it in 1 quarter.
  • Anson Funds Management's Microbot Medical position peaked at $854K in Q1 2016.
  • 22 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2016.

Based on Anson Funds Management's 13F filing for Q2 2016, filed 12 Aug 2016.